Combining chemical synthesis, biological testing, and mass spectrometry into a single integrated workflow could help researchers move more quickly against cancer drug targets.

Sacramento, California - June 29, 2026 - PRESSADVANTAGE - Silverback Digital Marketing has released an announcement ...

Meta pauses MCI after private conversations and employee data were exposed inside the company, renewing concerns over AI ...

H acker houses are popping up everywhere in San Francisco. “You could just walk a few blocks” in many neighborhoods, Amber ...

TWICE connected with Ralph Newhouse, CEO of CHEFMAN and CHEF iQ, who shared his insights into the state of the appliance ...

Elon Musk is best known as the CEO of Tesla Inc and SpaceX. Just weeks before his 55th birthday, Musk became the world’s ...

Step 1: First, you need to make an account on the CircuitDigest Cloud. If you already have one, just go to the CircuitDigest ...

The most efficient software no longer carries screens for people — it carries atomic commands that AI agents run while ...

Spielberg's divisive 2001 film looks far more prescient 25 years on, tackling the ChatGPT era with alarming urgency ...

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to dramatically accelerate one of the slowest ...

The job market is changing fast. From AI automation to shifting industries, see 14 jobs that are disappearing—and what to ...